Form 4 for LRCX Lam Research
Accepted 2024-01-04 00:00:00 ET · period of report 2024-01-03 · accession 0000707549-24-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-04 | 2024-01-03 | LRCX | Hahn Ava | CLO, SVP | S - Sale+OE | $732.00 | -2,342 | 3,433 | -41% | -$1.71M |
| D | 2024-01-04 | 2024-01-03 | LRCX | Hahn Ava | CLO, SVP | M - OptEx | $300.33 | +2,342 | 5,775 | +68% | +$703.4K |
| D | 2024-01-04 | 2024-01-03 | LRCX | Hahn Ava | CLO, SVP | M - OptEx | $0.00 | -2,342 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-03 | S | D | 2,342 | $732.00 | 3,433 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2023. (F2) The amount reported includes shares subject to unvested restricted stock units. |
| 2 | Common | Common Stock | 2024-01-03 | M | A | 2,342 | $300.33 | 5,775 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2023. (F2) The amount reported includes shares subject to unvested restricted stock units. |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2024-01-03 | M | D | 2,342 | $0.00 | 0 | D | $300.33 · — to 2027-03-02 | 2,342 Common Stock | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2023. (F3) The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023. |